Useful substituted 2,3-dihydro [1,2-c] quinazolin derivatives for the treatment of hyperproliferative diseases and angiogenesis-related disorders

The present invention relates to novel 2,3-dihydro [1,2-c] quinazolin compounds, pharmaceutical compositions containing such compounds, and phosphotidylinositol-3-kinase (PI3K) inhibition and phosphotidylinositol -3 - kinase (PI3K) for the treatment of diseases associated with the activity, particularly for treating hyperproliferative diseases and / or angiogenic diseases, in combination with, or other active ingredients as a single agent, these compounds or the use of the composition.